Doing things out of proper sequence can require a do-over.  But in law, as elsewhere, the do-over may come too late. 

Just ask Abraxis, a drug maker that today lost a lawsuit because the company it bought patents from didn't own them at the time.

Abraxis signed an Asset Purchase Agreement with AstraZeneca in April 2006.